Add Row

Add Element

update

My Wellness Train Network

update

Add Element

Menu 1
Menu 2
Menu 3
Menu 4
Menu 5
Menu 6

Add Element

update
update
update
update
update
update
update

January 20.2025

2 Minutes Read

How Mitch Kahn Transformed His Health: An Inspiring Weight Loss Journey

Older man exercising with dumbbells, showing weight loss progress.

The Inspiring Journey of Transformation

At 71 years old, Mitch Kahn's journey to reclaiming his health and fitness is nothing short of remarkable. After retiring in 2008, Mitch found himself grappling with an unhealthy lifestyle characterized by poor eating habits and a lack of physical activity that left him weighing 265 pounds. Recognizing the urgent need for change, he embarked on a radical transformation, one that would not only result in a 75-pound weight loss but also profound improvements in his overall health.

First Steps: Research and Learning

The turning point for Mitch wasn't a complicated workout plan or a drastic diet; it was his commitment to seeking knowledge. He dove into fitness literature and began following experts who inspired him. By learning about nutrition and exercise, he transitioned to a more plant-based diet focused on whole foods, steering clear of processed options. Mitch's meticulous approach to research—often characterized by his desire to know as much as possible—translated into actionable steps in his daily routine.

Building a Consistent Routine

Mitch's newfound knowledge laid the groundwork for a strong exercise regimen. He adopted a balanced routine of strength training and cardio, lifting weights four times a week and integrating daily walks and sprint workouts. By focusing on compound movements like squats and presses, he maximized efficiency and built functional strength. This disciplined approach was key to shedding the pounds quickly while simultaneously lowering his cholesterol and blood pressure.

From Personal Success to Helping Others

What began as a personal journey evolved into a passion for fitness training. After gaining certifications in personal training and specialization in areas like functional fitness and geriatric training, Mitch found himself helping others achieve their wellness goals. During the COVID-19 pandemic, he expanded his reach through social media, encouraging others to stay active amid isolation through daily workout videos. His Instagram account, @foreverfitwithmitch, became a beacon of hope and guidance for many.

Motivation Beyond Self

Mitch’s story is not just about weight loss; it’s about the profound realization that anyone can alter their health trajectory at any age. His mission is to inspire others to take the first step towards a healthier lifestyle, reinforcing the idea that commitment and informed choices can lead to incredible transformations. Mitch Kahn stands as a living testament to the power of perseverance and the importance of being a role model for future generations.

Men's Wellness

28 Views

0 Comments

Write A Comment

Related Posts All Posts

01.19.2026

FDA Expert Panel Calls for Expanded Access to Testosterone Replacement Therapy

Update FDA Panel's Bold Move: Expanding Access to Testosterone Replacement Therapy A recent meeting of an FDA expert panel has sparked conversations about the future of testosterone replacement therapy (TRT) in the United States. With growing evidence challenging the longstanding restrictions surrounding TRT, the panel is passionately advocating for expanded access for men nationwide. As they pushed for a reevaluation of TRT’s restrictive regulations, they highlighted the public health imperative behind their recommendations. Understanding the Current Landscape of TRT Festering underutilization has led many to question current FDA restrictions on TRT, which is only approved for specific medical conditions such as testicular dysfunction and pituitary disorders. Experts argue that this narrow view does not account for age-related testosterone deficiency—a growing concern as lifestyle-related health challenges rise. Renowned urologist Dr. Helen L. Bernie asserts, "If we want to close the mortality gap amongst men, we must recognize testosterone deficiency as a public health issue." This sentiment echoes across the panel, signaling a shift in understanding testosterone’s role in male health. Reassessing the Risks and Benefits of TRT Historically, concerns regarding TRT linked it to increased risks of cardiovascular diseases and prostate cancer. However, recent substantial clinical trials have found these risks either minimal or unfounded, leading to renewed support from the panel for the therapy. Notably, the TRAVERSE trial debunked the cardiovascular stress often associated with TRT, showing no significant difference in heart attack or stroke incidents compared to placebo in men with hypogonadism. A Future with Broader Indications? The FDA panel’s readiness to expand the approved indications for TRT may unfold a new chapter in men’s health. They recommend that the agency consider testosterone therapy for age-related low testosterone, recognizing that many men face hormonal challenges due to sedentary lifestyles and growing obesity rates. This expansion would align the FDA’s stance more closely with guidelines from organizations like the American Urological Association, which advocate for broader applications of TRT. Revisiting Testosterone’s Controlled Substance Classification Another pivotal recommendation from the FDA panel is the declassification of testosterone from Schedule III controlled substances. Current classifications hinder accessibility and treatment consistency among healthcare providers. Experts believe that this change could facilitate proper therapy channels, ensuring that men receive testosterone through qualified specialists rather than questionable clinics. Dr. Franck Mauvais-Jarvis emphasized, "Removing testosterone's Schedule III status can empower providers to prescribe it with confidence and encourage patients to seek appropriate treatment." However, not all experts share this perspective; there are concerns that easier access could lead to misuse without proper guidance. Next Steps in Men’s Health The future of TRT may very well hinge on the FDA's willingness to heed the panel's recommendations. In a climate where men's health issues often take a backseat, these developments offer new hope for many. If adopted, these changes could revolutionize how testosterone deficiency is perceived and treated. As we wait for regulatory updates, awareness and appropriate discussions about TRT will be vital for men seeking to enhance their health and longevity. To navigate the complexities of TRT, individuals must seek professional medical advice tailored to their unique health needs. If you're curious about how TRT could benefit your health journey, call us today at 984-238-6164 or email us at tom@mywellnesstrain.com.

10.23.2025

Investigating Prostate Cancer: How Enzalutamide Lowers Death Risk by Over 40%

Update The Breakthrough in Prostate Cancer TreatmentProstate cancer, a leading cause of cancer-related mortality among men globally, has seen a significant breakthrough with the introduction of enzalutamide in combination with leuprolide. Recent studies indicate that this drug combination not only enhances survival rates in patients but also changes the approach to treatment timing, potentially allowing for a more aggressive intervention during the early stages of biochemically recurrent disease.What the Research RevealedAccording to findings shared during the European Society for Medical Oncology (ESMO) Congress, the combination therapy significantly reduces the risk of death among high-risk prostate cancer patients. Specifically, the phase 3 EMBARK trial found that pairing enzalutamide, an androgen receptor blocker, with leuprolide, a hormone therapy, leads to an almost 40% lower risk of mortality in men whose cancer recurred after initial treatment with surgery or radiation. The overall survival rate after eight years for those on the combined therapy was 78.9%, compared to just 69.5% for those receiving leuprolide alone.Understanding Prostate Cancer RecurrenceFor many patients, the journey with prostate cancer is fraught with uncertainty, especially when the cancer returns after what was believed to be successful primary treatment. The presence of rapidly rising prostate-specific antigen (PSA) levels often signifies a higher risk of metastasis. In fact, experts stress that the shorter the time it takes for PSA levels to double, the more aggressive the disease likely is. Thus, the new findings about enzalutamide combined with leuprolide provide a glimmer of hope.Clinical Implications and Patient OutcomesThis combination is now showing promise as a new standard of care in managing high-risk recurrent prostate cancer. It is crucial for both patients and healthcare providers to weigh the potential benefits against possible treatment side effects, as aggressive treatment approaches can sometimes lead to overtreatment and a range of adverse effects. The study found that while serious adverse effects were slightly higher in patients taking enzalutamide, they remained under 10% for the majority.Future DirectionsThe implications of this research extend beyond just numbers; they paint a picture of a future where early and proactive treatment strategies can significantly impact survival. As research continues to unfold, it could pave the way for personalized medicine approaches tailored to individual patient profiles by taking into account the aggressiveness of their cancer.Make Informed Health ChoicesUnderstanding new treatment options can be empowering for patients and their families. If you or a loved one is navigating prostate cancer treatment, consider discussing these findings with your healthcare provider to see if this new therapy could be the right option for you.

09.08.2025

Prostate Cancer Cases Rise After Decade of Decline: What You Need to Know

Update Prostate Cancer Cases on the Rise: An Alarming Trend The recent surge in prostate cancer diagnoses is raising red flags across the medical community. After witnessing a steady decline over the past few decades, prostate cancer rates have reversed course, displaying a concerning annual increase of 3% from 2014 to 2021. This news comes amid alarming statistics from the American Cancer Society (ACS) predicting 313,780 new cases and 35,770 deaths in 2025 alone. The growth in diagnoses is particularly troublesome as it is largely driven by advanced cases, often diagnosed in men as young as 55, significantly increasing the urgency for proactive screening and detection strategies. Understanding the Implications of Late-Stage Diagnoses Late-stage prostate cancer cases—instances where cancer has metastasized to other areas of the body—have seen increases as high as 6.2% each year. Mortality rates, while once declining, have decelerated to a meager 0.6% reduction annually over the past decade. This trend begs the question: Are our current screening recommendations adequate to combat this deadly disease? The Role of PSA Screening in Prostate Cancer Detection Eyebrows are raised regarding the recommendations set by the U.S. Preventive Services Task Force (USPSTF), which downgraded PSA screenings to a “D” score for men over 70 in the early 2010s. For men ages 55-59, the guidelines remain a “C,” suggesting that periodic screening may be considered. Medical professionals are increasingly advocating for a reevaluation of these recommendations to mitigate the alarming trends in late-stage diagnoses. Empowering Men's Health: The Importance of Early Detection and Awareness The increasing rate of prostate cancer reflects a broader issue of men's health awareness. Proactive approaches, like regular health screenings and discussions about symptoms with healthcare providers, are crucial in early detection. Men's health is often shrouded in stigma, but understanding one's risks can significantly impact outcomes. Encouraging men to take charge of their health through educated conversations and timely screenings can lead to earlier interventions and better prognosis. What You Can Do: Proactive Steps for Healthier Living To combat the rising rates of prostate cancer and to foster a culture of health and wellness, consider incorporating lifestyle adjustments that prioritize health. This includes a balanced diet, physical activity, and regular medical check-ups. Chronic illnesses, such as type 2 diabetes or heart disease, can compound risks for cancer, emphasizing the necessity of holistic health management. Consider reaching out for mental health support if you feel overwhelmed, as emotional well-being is an essential component of overall health. For more personalized advice, call us today at 984-238-6164 or email us at tom@mywellnesstrain.com for comprehensive wellness support and guidance.

How Mitch Kahn Transformed His Health: An Inspiring Weight Loss Journey

The Inspiring Journey of Transformation

First Steps: Research and Learning

Building a Consistent Routine

From Personal Success to Helping Others

Motivation Beyond Self

Terms of Service

Privacy Policy

Core Modal Title